Inventiva S.A. ADR (IVA): Price and Financial Metrics Recent IPO

Inventiva S.A. ADR (IVA) Recent IPO

Today's Latest Price: $13.35 USD

0.26 (-1.91%)

Updated Nov 24 3:41pm

Add IVA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

IVA Stock Price Chart Interactive Chart >

Price chart for IVA

IVA Price/Volume Stats

Current price $13.35 52-week high $15.95
Prev. close $13.61 52-week low $9.01
Day low $13.20 Volume 4,300
Day high $13.66 Avg. volume 61,417
50-day MA $12.84 Dividend yield N/A
200-day MA $0.00 Market Cap 509.52M

Inventiva S.A. ADR (IVA) Company Bio

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

IVA Latest News Stream

Event/Time News Detail
Loading, please wait...

IVA Latest Social Stream

Loading social stream, please wait...

View Full IVA Social Stream

Latest IVA News From Around the Web

Below are the latest news stories about Inventiva SA that investors may wish to consider to help them evaluate IVA as an investment opportunity.

Inventiva files for IPO

Fresh off positive results from a mid-stage study evaluating its lead drug in nonalcoholic steatohepatitis ((NASH)), French biotech Inventiva S.A. (IVA) has filed a preliminary prospectus for a $90M IPO.Lead candidate is lanifibranor, a small molecule pan-PPAR inhibitor for the potential treatment of NASH, a huge market opportunity for the...

Seeking Alpha | June 19, 2020

Read More 'IVA' Stories Here

IVA Price Returns

1-mo 5.83%
3-mo 12.85%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7043 seconds.